Can an effective SARS-CoV-2 vaccine be developed for the older population?
Abstract The emergence of SARS-CoV-2 and its inordinately rapid spread is posing severe challenges to the wellbeing of millions of people worldwide, health care systems and the global economy. While many younger people experience no or mild symptoms on infection, older adults are highly susceptible...
Main Authors: | Graham Pawelec, Nan-ping Weng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | Immunity & Ageing |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12979-020-00180-2 |
Similar Items
-
Unanticipated efficacy of SARS-CoV-2 vaccination in older adults
by: Graham Pawelec, et al.
Published: (2021-02-01) -
Validation of the effectiveness of SARS-CoV-2 vaccines in older adults in “real-world” settings
by: Nan-ping Weng, et al.
Published: (2021-09-01) -
Differential Tropism of SARS-CoV and SARS-CoV-2 in Bat Cells
by: Susanna K.P. Lau, et al.
Published: (2020-12-01) -
Lack of Susceptibility to SARS-CoV-2 and MERS-CoV in Poultry
by: David L. Suarez, et al.
Published: (2020-12-01) -
Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
by: Sicong Yu, et al.
Published: (2021-06-01)